Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 118.91 billion. The enterprise value is 110.38 billion.

Market Cap	118.91B
Enterprise Value	110.38B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Remed has 31.21 million shares outstanding. The number of shares has increased by 9.33% in one year.

Current Share Class	31.21M
Shares Outstanding	31.21M
Shares Change (YoY)	+9.33%
Shares Change (QoQ)	-27.17%
Owned by Insiders (%)	35.27%
Owned by Institutions (%)	2.72%
Float	19.98M

Valuation Ratios

The trailing PE ratio is 15.90.

PE Ratio	15.90
Forward PE	n/a
PS Ratio	4.46
PB Ratio	2.77
P/TBV Ratio	3.04
P/FCF Ratio	75.46
P/OCF Ratio	55.97
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.37, with an EV/FCF ratio of 70.04.

EV / Earnings	14.32
EV / Sales	4.14
EV / EBITDA	37.37
EV / EBIT	67.27
EV / FCF	70.04

Financial Position

The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.14.

Current Ratio	2.65
Quick Ratio	1.98
Debt / Equity	0.14
Debt / EBITDA	1.95
Debt / FCF	3.70
Interest Coverage	1.46

Financial Efficiency

Return on equity (ROE) is 21.17% and return on invested capital (ROIC) is 2.14%.

Return on Equity (ROE)	21.17%
Return on Assets (ROA)	1.78%
Return on Invested Capital (ROIC)	2.14%
Return on Capital Employed (ROCE)	3.73%
Revenue Per Employee	306.68M
Profits Per Employee	88.62M
Employee Count	87
Asset Turnover	0.45
Inventory Turnover	1.82

Taxes

In the past 12 months, Remed has paid 645.78 million in taxes.

Income Tax	645.78M
Effective Tax Rate	7.69%

Stock Price Statistics

The stock price has increased by +18.80% in the last 52 weeks. The beta is 0.70, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+18.80%
50-Day Moving Average	3,476.20
200-Day Moving Average	3,426.88
Relative Strength Index (RSI)	48.05
Average Volume (20 Days)	366,373

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 26.68 billion and earned 7.71 billion in profits. Earnings per share was 239.58.

Revenue	26.68B
Gross Profit	15.10B
Operating Income	1.68B
Pretax Income	8.39B
Net Income	7.71B
EBITDA	3.00B
EBIT	1.68B
Earnings Per Share (EPS)	239.58

Full Income Statement

Balance Sheet

The company has 16.48 billion in cash and 5.83 billion in debt, giving a net cash position of 10.65 billion or 341.10 per share.

Cash & Cash Equivalents	16.48B
Total Debt	5.83B
Net Cash	10.65B
Net Cash Per Share	341.10
Equity (Book Value)	42.86B
Book Value Per Share	1,329.73
Working Capital	19.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.12 billion and capital expenditures -548.79 million, giving a free cash flow of 1.58 billion.

Operating Cash Flow	2.12B
Capital Expenditures	-548.79M
Free Cash Flow	1.58B
FCF Per Share	50.49

Full Cash Flow Statement

Margins

Gross margin is 56.60%, with operating and profit margins of 6.31% and 28.90%.

Gross Margin	56.60%
Operating Margin	6.31%
Pretax Margin	31.46%
Profit Margin	28.90%
EBITDA Margin	11.23%
EBIT Margin	6.31%
FCF Margin	5.91%

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.33%
Shareholder Yield	n/a
Earnings Yield	6.48%
FCF Yield	1.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 5.54 and a Piotroski F-Score of 7.

Altman Z-Score	5.54
Piotroski F-Score	7